vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and IPG PHOTONICS CORP (IPGP). Click either name above to swap in a different company.

IPG PHOTONICS CORP is the larger business by last-quarter revenue ($274.5M vs $270.8M, roughly 1.0× HUTCHMED (China) Ltd). IPG PHOTONICS CORP runs the higher net margin — 4.8% vs 0.7%, a 4.1% gap on every dollar of revenue. On growth, IPG PHOTONICS CORP posted the faster year-over-year revenue change (17.1% vs -16.5%). IPG PHOTONICS CORP produced more free cash flow last quarter ($10.9M vs $3.4M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

IPG Photonics Corporation is a manufacturer of fiber lasers. IPG Photonics developed and commercialized optical fiber lasers, which are used in a variety of applications including materials processing, medical applications and telecommunications. IPG has manufacturing facilities in the United States, Germany, Russia and Italy.

HCM vs IPGP — Head-to-Head

Bigger by revenue
IPGP
IPGP
1.0× larger
IPGP
$274.5M
$270.8M
HCM
Growing faster (revenue YoY)
IPGP
IPGP
+33.7% gap
IPGP
17.1%
-16.5%
HCM
Higher net margin
IPGP
IPGP
4.1% more per $
IPGP
4.8%
0.7%
HCM
More free cash flow
IPGP
IPGP
$7.6M more FCF
IPGP
$10.9M
$3.4M
HCM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCM
HCM
IPGP
IPGP
Revenue
$270.8M
$274.5M
Net Profit
$2.0M
$13.3M
Gross Margin
37.7%
36.1%
Operating Margin
-13.2%
1.2%
Net Margin
0.7%
4.8%
Revenue YoY
-16.5%
17.1%
Net Profit YoY
-83.6%
69.8%
EPS (diluted)
$0.00
$0.30

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
IPGP
IPGP
Q4 25
$270.8M
$274.5M
Q3 25
$250.8M
Q2 25
$277.7M
$250.7M
Q1 25
$324.5M
$227.8M
Q4 24
$234.3M
Q3 24
$233.1M
Q2 24
$305.7M
$257.6M
Q1 24
$252.0M
Net Profit
HCM
HCM
IPGP
IPGP
Q4 25
$2.0M
$13.3M
Q3 25
$7.5M
Q2 25
$455.0M
$6.6M
Q1 25
$11.9M
$3.8M
Q4 24
$7.8M
Q3 24
$-233.6M
Q2 24
$25.8M
$20.2M
Q1 24
$24.1M
Gross Margin
HCM
HCM
IPGP
IPGP
Q4 25
37.7%
36.1%
Q3 25
39.5%
Q2 25
0.1%
37.3%
Q1 25
48.0%
39.4%
Q4 24
38.6%
Q3 24
23.2%
Q2 24
41.1%
37.3%
Q1 24
38.7%
Operating Margin
HCM
HCM
IPGP
IPGP
Q4 25
-13.2%
1.2%
Q3 25
3.1%
Q2 25
-1.3%
0.0%
Q1 25
-5.0%
0.8%
Q4 24
6.0%
Q3 24
-108.7%
Q2 24
-9.0%
4.7%
Q1 24
7.6%
Net Margin
HCM
HCM
IPGP
IPGP
Q4 25
0.7%
4.8%
Q3 25
3.0%
Q2 25
163.8%
2.6%
Q1 25
3.7%
1.6%
Q4 24
3.3%
Q3 24
-100.2%
Q2 24
8.4%
7.8%
Q1 24
9.6%
EPS (diluted)
HCM
HCM
IPGP
IPGP
Q4 25
$0.00
$0.30
Q3 25
$0.18
Q2 25
$0.52
$0.16
Q1 25
$0.01
$0.09
Q4 24
$0.27
Q3 24
$-5.33
Q2 24
$0.03
$0.45
Q1 24
$0.52

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
IPGP
IPGP
Cash + ST InvestmentsLiquidity on hand
$1.4B
$839.3M
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$1.2B
$2.1B
Total Assets
$1.8B
$2.4B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
IPGP
IPGP
Q4 25
$1.4B
$839.3M
Q3 25
$870.4M
Q2 25
$1.4B
$899.6M
Q1 25
$836.1M
$926.9M
Q4 24
$930.2M
Q3 24
$1.0B
Q2 24
$802.5M
$1.1B
Q1 24
$1.1B
Total Debt
HCM
HCM
IPGP
IPGP
Q4 25
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
Q3 24
Q2 24
$82.1M
Q1 24
Stockholders' Equity
HCM
HCM
IPGP
IPGP
Q4 25
$1.2B
$2.1B
Q3 25
$2.1B
Q2 25
$1.2B
$2.1B
Q1 25
$759.9M
$2.1B
Q4 24
$2.0B
Q3 24
$2.1B
Q2 24
$740.1M
$2.3B
Q1 24
$2.3B
Total Assets
HCM
HCM
IPGP
IPGP
Q4 25
$1.8B
$2.4B
Q3 25
$2.4B
Q2 25
$1.8B
$2.4B
Q1 25
$1.3B
$2.3B
Q4 24
$2.3B
Q3 24
$2.4B
Q2 24
$1.3B
$2.5B
Q1 24
$2.6B
Debt / Equity
HCM
HCM
IPGP
IPGP
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
Q3 24
Q2 24
0.11×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
IPGP
IPGP
Operating Cash FlowLast quarter
$8.2M
$28.8M
Free Cash FlowOCF − Capex
$3.4M
$10.9M
FCF MarginFCF / Revenue
1.2%
4.0%
Capex IntensityCapex / Revenue
1.8%
6.5%
Cash ConversionOCF / Net Profit
4.21×
2.17×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$-3.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
IPGP
IPGP
Q4 25
$8.2M
$28.8M
Q3 25
$35.3M
Q2 25
$-72.9M
$-2.2M
Q1 25
$40.3M
$13.4M
Q4 24
$73.8M
Q3 24
$66.1M
Q2 24
$-39.8M
$53.5M
Q1 24
$54.6M
Free Cash Flow
HCM
HCM
IPGP
IPGP
Q4 25
$3.4M
$10.9M
Q3 25
$14.6M
Q2 25
$-82.2M
$-17.6M
Q1 25
$32.5M
$-11.4M
Q4 24
$50.6M
Q3 24
$43.0M
Q2 24
$-49.9M
$29.2M
Q1 24
$26.5M
FCF Margin
HCM
HCM
IPGP
IPGP
Q4 25
1.2%
4.0%
Q3 25
5.8%
Q2 25
-29.6%
-7.0%
Q1 25
10.0%
-5.0%
Q4 24
21.6%
Q3 24
18.4%
Q2 24
-16.3%
11.3%
Q1 24
10.5%
Capex Intensity
HCM
HCM
IPGP
IPGP
Q4 25
1.8%
6.5%
Q3 25
8.3%
Q2 25
3.3%
6.1%
Q1 25
2.4%
10.9%
Q4 24
9.9%
Q3 24
9.9%
Q2 24
3.3%
9.4%
Q1 24
11.1%
Cash Conversion
HCM
HCM
IPGP
IPGP
Q4 25
4.21×
2.17×
Q3 25
4.73×
Q2 25
-0.16×
-0.34×
Q1 25
3.38×
3.58×
Q4 24
9.44×
Q3 24
Q2 24
-1.54×
2.65×
Q1 24
2.27×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCM
HCM

Segment breakdown not available.

IPGP
IPGP

Materials Processing$232.8M85%
Laser And Non Laser Systems$38.8M14%
Transferred Over Time$5.3M2%

Related Comparisons